Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ragni, M. V.
Right arrow Articles by Zimmerman, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ragni, M. V.
Right arrow Articles by Zimmerman, D. H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

AIDS retrovirus antibodies in hemophiliacs treated with factor VIII or factor IX concentrates, cryoprecipitate, or fresh frozen plasma: prevalence, seroconversion rate, and clinical correlations

MV Ragni, GE Tegtmeier, JA Levy, LS Kaminsky, JH Lewis, JA Spero, FA Bontempo, C Handwerk-Leber, WL Bayer and DH Zimmerman

Antibodies to the AIDS retrovirus, specifically to human T cell lymphotropic virus, type III, and AIDS-associated retrovirus, were detected with increasing prevalence in a population of 190 hemophiliacs from western Pennsylvania between 1981 and 1984: 7.7% in 1981, 20.0% in 1982, 45.5% in 1983, and 62.5% in 1984. The seropositive included approximately three fourths of those receiving factor VIII concentrate, nearly one third of those receiving factor IX concentrate, nearly one fifth of those receiving cryoprecipitate, and none of those receiving fresh frozen plasma. The seroconversion rate, determined on 43 seropositive hemophiliacs from this group who were serially sampled, was 0% in 1977, 4.7% in 1978, 4.9% in 1979, 2.6% in 1980, 10.5% in 1981, 52.9% in 1982, 87.5% in 1983, and 100% in 1984. Of 27 seropositive for three or more years (since 1982 or before), four (15%) have developed AIDS and seven (26%), diffuse lymphadenopathy (ARC); of 16 seropositive for less than three years, none has developed AIDS and three (19%) have developed ARC. The mean time from seroconversion to onset of ARC, 0.8 +/- 0.2 years (SEM), was shorter (P less than .001) than the time to onset of AIDS, 4.1 +/- 0.6 years. These findings confirm the widespread presence of AIDS retrovirus and support the association of these retroviruses with the acquired immunodeficiency syndrome and related conditions.

Volume 67, Issue 3, pp. 592-595, 03/01/1986
Copyright © 1986 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
D. M. Arnold, J. A. Julian, I. R. Walker, and for the Association of Hemophilia Clinic Directors
Mortality rates and causes of death among all HIV-positive individuals with hemophilia in Canada over 21 years of follow-up
Blood, July 15, 2006; 108(2): 460 - 464.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. R. Arruda, J. N. Hagstrom, J. Deitch, T. Heiman-Patterson, R. M. Camire, K. Chu, P. A. Fields, R. W. Herzog, L. B. Couto, P. J. Larson, et al.
Posttranslational modifications of recombinant myotube-synthesized human factor IX
Blood, January 1, 2001; 97(1): 130 - 138.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
C. M. Tsoukas, N. F. Bernard, M. Abrahamowicz, H. Strawczynski, G. Growe, R. T. Card, and P. Gold
Effect of Splenectomy on Slowing Human Immunodeficiency Virus Disease Progression
Arch Surg, January 1, 1998; 133(1): 25 - 31.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
L. W. Hoyer
Hemophilia A
N. Engl. J. Med., January 6, 1994; 330(1): 38 - 47.
[Full Text]


Home page
ANN INTERN MEDHome page
M. E. Eyster, H. J. Alter, L. M. Aledort, S. Quan, A. Hatzakis, and J. J. Goedert
Heterosexual Co-transmission of Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)
Ann Intern Med, November 15, 1991; 115(10): 764 - 768.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
M. A. Dew, M. V. Ragni, and P. Nimorwicz
Infection With Human Immunodeficiency Virus and Vulnerability to Psychiatric Distress: A Study of Men With Hemophilia
Arch Gen Psychiatry, August 1, 1990; 47(8): 737 - 744.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
H. Masur, F. P. Ognibene, R. Yarchoan, J. H. Shelhamer, B. F. Baird, W. Travis, A. F. Suffredini, L. Deyton, J. A. Kovacs, J. Falloon, et al.
CD4 Counts as Predictors of Opportunistic Pneumonias in Human Immunodeficiency Virus (HIV) Infection
Ann Intern Med, August 1, 1989; 111(3): 223 - 231.
[Abstract] [PDF]


Home page
JAMAHome page
J. Jason, K.-J. Lui, M. V. Ragni, N. A. Hessol, and W. W. Darrow
Risk of Developing AIDS in HIV-Infected Cohorts of Hemophilic and Homosexual Men
JAMA, February 3, 1989; 261(5): 725 - 727.
[Abstract] [PDF]


Home page
JAMAHome page
Leads From the MMWR
JAMA, October 9, 1987; 258(14): 1872 - 1881.
[PDF]


Home page
JAMAHome page
M. R. Bibler, H. J. Luber, H. I. Glueck, and S. A. Estes
Disseminated Sporotrichosis in a Patient With HIV Infection After Treatment for Acquired Factor VIII Inhibitor
JAMA, December 12, 1986; 256(22): 3125 - 3126.
[Abstract] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1986 by American Society of Hematology         Online ISSN: 1528-0020